Advertisement
Screener

Evolent Health, Inc. (EVH) Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims

2.9 / 5 stars · 43/75 Roast Me

Evolent Health, Inc. Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims

Evolent Health, Inc. (EVH) reported Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims of $763.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1 · last filed 2026-08-06

  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-06-30 was $461.52M, a 115.41% increase year-over-year.
  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2026-03-31 was $301.78M, a 46.50% increase year-over-year.
  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-12-31 was $243.16M, a 37.94% decline year-over-year.
  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for the quarter ending 2025-09-30 was $243.91M, a 32.25% decline year-over-year.
  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2025 was $907.30M, a 38.82% decline from fiscal 2024.
  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2024 was $1.48B, a 66.42% increase from fiscal 2023.
  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2023 was $891.09M, a 49.95% increase from fiscal 2022.
  • Evolent Health, Inc. liability for unpaid claims and claims adjustment expense, incurred claims for fiscal 2022 was $594.25M, a 27.82% increase from fiscal 2021.
Period endLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 3 monthLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 6 monthLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 9 monthLiability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims 12 month
2026-06-30$461.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$763.30M
10-Q · filed 2026-08-06
$1.01B
derived: sum of 3 quarters · filed 2026-08-06
$1.25B
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$301.78M
10-Q · filed 2026-05-07
$544.93M
derived: sum of 2 quarters · filed 2026-05-07
$788.84M
derived: sum of 3 quarters · filed 2026-05-07
$1.00B
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$243.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$487.06M
derived: sum of 2 quarters · filed 2026-02-25
$701.31M
derived: sum of 3 quarters · filed 2026-08-06
$907.30M
10-K · filed 2026-02-25
2025-09-30$243.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$458.15M
derived: sum of 2 quarters · filed 2026-08-06
$664.15M
10-Q · filed 2025-11-07
$1.06B
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$214.25M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$420.24M
10-Q · filed 2026-08-06
$812.05M
derived: sum of 3 quarters · filed 2026-08-06
$1.17B
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$205.99M
10-Q · filed 2026-05-07
$597.80M
derived: sum of 2 quarters · filed 2026-05-07
$957.82M
derived: sum of 3 quarters · filed 2026-05-07
$1.33B
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$391.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$751.83M
derived: sum of 2 quarters · filed 2026-02-25
$1.12B
derived: sum of 3 quarters · filed 2026-02-25
$1.48B
10-K · filed 2026-02-25
2024-09-30$360.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$731.48M
derived: sum of 2 quarters · filed 2025-11-07
$1.09B
10-Q · filed 2025-11-07
$1.39B
derived: sum of 4 quarters · filed 2025-11-07
2024-06-30$371.46M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
$731.16M
10-Q · filed 2025-08-11
$1.03B
derived: sum of 3 quarters · filed 2025-08-11
$1.26B
derived: sum of 4 quarters · filed 2025-08-11
2024-03-31$359.69M
10-Q · filed 2025-05-09
$658.78M
derived: sum of 2 quarters · filed 2025-05-09
$891.80M
derived: sum of 3 quarters · filed 2025-05-09
$1.09B
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$299.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21
$532.10M
derived: sum of 2 quarters · filed 2025-02-21
$730.33M
derived: sum of 3 quarters · filed 2025-02-21
$891.09M
10-K · filed 2025-02-21
2023-09-30$233.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$431.24M
derived: sum of 2 quarters · filed 2024-11-08
$592.00M
10-Q · filed 2024-11-08
$722.90M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$198.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$358.99M
10-Q · filed 2024-08-09
$489.88M
derived: sum of 3 quarters · filed 2024-08-09
$683.84M
derived: sum of 4 quarters · filed 2024-08-09
2023-03-31$160.76M
10-Q · filed 2024-05-10
$291.66M
derived: sum of 2 quarters · filed 2024-05-10
$485.61M
derived: sum of 3 quarters · filed 2024-05-10
$645.83M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$130.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23
$324.85M
derived: sum of 2 quarters · filed 2024-02-23
$485.07M
derived: sum of 3 quarters · filed 2024-02-23
$594.25M
10-K · filed 2024-02-23
2022-09-30$193.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$354.17M
derived: sum of 2 quarters · filed 2023-11-02
$463.35M
10-Q · filed 2023-11-02
$544.51M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$160.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$269.39M
10-Q · filed 2023-08-03
$350.56M
derived: sum of 3 quarters · filed 2023-08-03
2022-03-31$109.17M
10-Q · filed 2023-05-04
$190.34M
derived: sum of 2 quarters · filed 2023-05-04
2021-12-31$81.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$464.91M
10-K · filed 2023-02-24
2021-09-30$383.75M
10-Q · filed 2022-11-03
2019-09-30$111.54M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$195.48M
derived: sum of 2 quarters · filed 2019-11-05
$273.89M
10-Q · filed 2019-11-05
2019-06-30$83.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$162.35M
10-Q · filed 2019-08-09
2019-03-31$78.41M
10-Q · filed 2019-05-09
2018-09-30$16.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$35.42M
derived: sum of 2 quarters · filed 2019-11-05
$52.17M
10-Q · filed 2019-11-05
2018-06-30$18.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$35.18M
10-Q · filed 2019-08-09
2018-03-31$16.75M
10-Q · filed 2019-05-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
FRANKLIN COVEY CO (FC)United States$0.195B123.76
GARTNER INC (IT)United States$11.326B11.20